Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV. We’re proudly sponsored by Bidav Insurance Group, visit lux-str.com if you’re ready to level up your insurance plans.
(0:00) Episode Preview
(2:21) Jeff’s background
(5:08) Teaching at MIT as a teenager
(8:22) What is gene therapy?
(11:53) Episode Sponsor: Bidav Insurance Group
(12:39) Gene therapy success stories
(16:11) What is HIV?
(20:14) AGT103 and the quest for a functional HIV cure
(23:22) AGT103’s Phase I results
(29:43) How gene therapy could revolutionize pharmaceuticals
(30:52) How to contact Addimmune
How I Invest with David Weisburd